Rx
Description
Emend (Aprepitant) is an antiemetic agent. It is typically used with other medications to help prevent nausea and vomiting caused by chemotherapy (cancer treatment). It may also have other uses.
Additional information
Emend (Aprepitant) is typically used once daily in the morning, for the 2 days following the chemotherapy treatment. However, your doctor or pharmacist may have suggested a different schedule that is more appropriate for you. Important: Follow the instructions on the label. Do not use more of this product, or more often, than prescribed. If you forget a dose, contact your pharmacist. Administer this drug with or without food. WARNING: EMEND may reduce the efficacy of hormonal contraceptives (hormonal contraceptives are birth control medicines. These medicines help prevent pregnancy). Alternative or backup methods should be used during and for 1 month following the last dose of EMEND. In addition to its desired action, Emend (Aprepitant) may cause some side effects, notably: It may cause diarrhea, stomach pain, upset stomach, vomiting. It may cause headaches, hair loss, and loss of appetite. It may cause cough, low blood pressure, fatigue, sleep disorders. Contraindications: Hypersensitivity to aprepitant or any component of the formulation, concurrent use with Pimozide. Animal reproduction studies have failed to demonstrate a risk to the fetus and there are no adequate and well-controlled studies in pregnant women. If you're planning a pregnancy or become pregnant, or breastfeeding contact your family doctor. A treatment with Emend (Aprepitant) requires regular monitoring by a doctor. Be sure to see your doctor for all regularly scheduled appointments.Emend (Aprepitant)
Warning
Each person may react differently to a treatment. If you think this medication may be causing side effects (including those described here, or others), talk to your doctor or pharmacist. He or she can help you to determine whether or not the medication is the source of the problem.
There are no reviews yet.
Reviews